MedTrace Logo

Components of Placebo Effects in Sadness

NCT03507959 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 159

Last updated 2020-12-10

No results posted yet for this study

Summary

Research has shown that placebo effects contribute substantially to clinical outcomes. Recent evidence suggests that placebos remain effective even if they are openly described as placebos (so-called Open-Label Placebos). In this study, the investigators examine components of open-label placebos and traditional deceptive placebos in an experimental study investigating sadness.

Conditions

  • Dysphoric Mood

Interventions

OTHER

OLP scientifically-objective

Participants are informed that they are about to take a placebo. The rationale for the effectivity of placebos is explained in a scientifically-objective manner.

OTHER

OLP personally-affective

Participants are informed that they are about to take a placebo. The rationale for the effectivity of placebos is explained in a personally-affective manner.

OTHER

DP scientifically-objective

Participants are informed that they are about to take an effective antidepressant. The rationale for the effectivity of the antidepressant is explained in a scientifically-objective manner.

OTHER

DP personally-affective

Participants are informed that they are about to take an effective antidepressant. The rationale for the effectivity of the antidepressant is explained in a personally-affective manner.

Sponsors & Collaborators

  • Philipps University Marburg

    lead OTHER

Principal Investigators

  • Tobias Kube, PhD · Philipps University Marburg

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-15
Primary Completion
2019-06-30
Completion
2020-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03507959 on ClinicalTrials.gov